{
    "2021-05-25": [
        [
            {
                "time": "",
                "original_text": "新冠疫苗多赚钱？辉瑞、Moderna赚翻，科兴Q1盈利100亿！其它国产企业如何？",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "科兴",
                        "盈利",
                        "辉瑞",
                        "Moderna"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业双周报",
                "features": {
                    "keywords": [
                        "医药生物",
                        "双周报"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "新冠疫苗放量供货，科兴中维一季度或暴赚100亿",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "科兴中维",
                        "放量供货",
                        "盈利"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物与智利签署新冠疫苗Ⅲ期临床试验合作协议",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "智利",
                        "新冠疫苗",
                        "临床试验",
                        "合作协议"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "信达证券：康泰生物（300601.SZ）四联苗快速放量，新品种将进入收获期，首予“买入”评级",
                "features": {
                    "keywords": [
                        "信达证券",
                        "康泰生物",
                        "四联苗",
                        "放量",
                        "新品种",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗企业2021年一季度报盘点 智飞生物营收净利均领跑",
                "features": {
                    "keywords": [
                        "疫苗企业",
                        "2021年",
                        "一季度",
                        "智飞生物",
                        "营收",
                        "净利"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "解盘：超百亿资金流入，炒股软件、证券、疫苗、医美领涨",
                "features": {
                    "keywords": [
                        "资金流入",
                        "炒股软件",
                        "证券",
                        "疫苗",
                        "医美",
                        "领涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "东吴证券 - 医药行业2021年中期策略报告：人口结构演变铸造医药长期牛市，建议超配医药【行业研究】",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "医药行业",
                        "2021年",
                        "中期策略",
                        "人口结构",
                        "长期牛市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗龙头一季度暴赚100亿？千亿港股“泄露”重磅信息，疫苗股开盘走强",
                "features": {
                    "keywords": [
                        "疫苗龙头",
                        "一季度",
                        "暴赚",
                        "港股",
                        "泄露",
                        "重磅信息",
                        "开盘走强"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[行情] A股生物疫苗涨幅居前，未名医药涨停，智飞生物、康泰生物涨超5%，沃森生物、康希诺、复星医药等也大幅高开",
                "features": {
                    "keywords": [
                        "A股",
                        "生物疫苗",
                        "涨幅",
                        "未名医药",
                        "涨停",
                        "智飞生物",
                        "康泰生物",
                        "沃森生物",
                        "康希诺",
                        "复星医药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块开盘大涨，未名医药一字涨停",
                "features": {
                    "keywords": [
                        "疫苗板块",
                        "开盘",
                        "大涨",
                        "未名医药",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股龙头一封中报泄露玄机，疫苗业绩开始兑现，这一万亿市值板块将起飞？",
                "features": {
                    "keywords": [
                        "港股",
                        "龙头",
                        "中报",
                        "泄露",
                        "疫苗业绩",
                        "市值",
                        "起飞"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[国金晨讯]洋河股份跟踪：渠道库存及价盘良性；美团深度：剖析持续进化竞争力的内核；康泰生物深度：丰富研发管线步入收获期",
                "features": {
                    "keywords": [
                        "国金晨讯",
                        "洋河股份",
                        "渠道库存",
                        "美团",
                        "康泰生物",
                        "研发管线",
                        "收获期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "远超预期！中国生物制药透露新冠疫苗到底有多赚钱！",
                "features": {
                    "keywords": [
                        "中国生物制药",
                        "新冠疫苗",
                        "赚钱"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "千亿港股“泄露”重磅信息，疫苗龙头一季度暴赚100亿？",
                "features": {
                    "keywords": [
                        "港股",
                        "泄露",
                        "重磅信息",
                        "疫苗龙头",
                        "一季度",
                        "暴赚"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}